Description
A secoiridoid glycoside with diverse biological activities; inhibits the growth of SNU-16 cells (IC50 = 12.4 µM after 48 hours) and increases apoptosis at 50 µM; reduces tumor growth in a SNU-16 nude mouse xenograft model in a dose-dependent manner; reduces plasma glucose levels in rat model of diabetes induced by STZ in a dose-dependent manner; reverses the STZ-induced increase in soleus muscle levels of Glut4 at 0.5 mg/kg; reduces parasite burden in the spleen of hamsters infected with L. donovani in a dose-dependent manner
Formal name: 5-ethenyl-4,4aS,5R,6S-tetrahydro-6-[[2-O-[(3,3′,5-trihydroxy[1,1′-biphenyl]-2-yl)carbonyl]-β-D-glucopyranosyl]oxy]-1H,3H-pyrano[3,4-c]pyran-1-one
Synonyms:
Molecular weight: 586.5
CAS: 21018-84-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antiparasitics|Antiprotozoals||Product Type|Biochemicals|Natural Products|Glycosides||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Parasitic Diseases|Leishmaniasis